Please assess the completion status of the following clinical trial:

Trial Title: Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Histologically proven adenocarcinoma of colon and rectum~* No prior chemotherapy or only adjuvant chemotherapy and/or radiotherapy~* Advanced, metastatic or recurrent not amenable to curative local therapy~* Measurable lesion(s)~* ECOG performance status 0 to 2~* Normal marrow, hepatic and renal function~* Provision of written informed consent~Exclusion Criteria:~* Active infection and/or severe comorbidity~* Known history of anaphylaxis of any origin

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).